She was one of the complainants in a Competition Commission case that resulted in antiretroviral medicines becoming affordable
Obituary | 20 March 2023
Cabotegravir is still unaffordable after two years
By Daniel Steyn
News | 1 December 2022
Experts commend the Department of Health’s efforts to secure lower prices in new contract
By Liezl Human
News | 16 November 2022
Former president repeated misconceptions about the disease when he addressed UNISA
News | 28 September 2022
This is mainly due to antiretroviral treatment and condom promotion, but male medical circumcision and behaviour change after HIV diagnosis had a role too
Science | 9 February 2022
A look back at the battle for the rights of HIV-positive prisoners
Analysis | 11 November 2021
Protesters speak of ignorance and bigotry from clinic staff
News | 19 October 2021
A case study suggests that people with HIV should be prioritised for Covid vaccination
Covid-19 Report | 10 July 2021
Progressive policies linked to drop in new infections in Southern Africa
By James Stent
Brief | 1 December 2020
We can do the same for Covid-19 and other diseases
Opinion | 1 December 2020
Injection much more effective than daily pills in preventing infection in women
News | 10 November 2020
But these medicines are well tolerated by patients
By James Stent
News | 1 October 2020
She is one of thousands providing essential care across the country
Feature | 21 August 2020
Veteran activist receives award for AIDS work
By Liezl Human
News | 3 July 2020
TAC activist who lived openly with HIV succumbs to Covid-19
Obituary | 1 July 2020
“Cabotegravir dosed every two months can successfully reduce HIV acquisition in at-risk MSM and transgender women”
By James Stent
News | 18 May 2020